1 |
Soriano, Joan B, et al., "Global, Regional, and National Deaths, Prevalence, Disability-Adjusted Life Years, and Years Lived with Disability for Chronic Obstructive Pulmonary Disease and Asthma, 1990-2015: a Systematic Analysis for the Global Burden of Disease Study 2015", The Lancet Respiratory Medicine, Vol.5, No.9, pp.691-706, 2017. https://doi.org/10.1016/S2213-2600(17)30293-X
DOI
|
2 |
Lin, S-H, et al., "Comorbid Pulmonary Disease and Risk of Community-Acquired Pneumonia in COPD Patients", The International Journal of Tuberculosis and Lung Disease, Vol.17, No.12, pp.1638-1644, 2013. https://doi.org/10.5588/ijtld.13.0330
DOI
|
3 |
Suissa, Samy, et al., "Inhaled Corticosteroids in COPD and the Risk of Serious Pneumonia", Thorax, Vol.68, No.11, pp.1029-1036, 2013. http://dx.doi.org/10.1136/thoraxjnl-2012-202872
DOI
|
4 |
Hwang, Yong Il, et al., "History of Pneumonia Is a Strong Risk Factor for Chronic Obstructive Pulmonary Disease (COPD) Exacerbation in South Korea: the Epidemiologic Review and Prospective Observation of COPD and Health in Korea (EPOCH) Study", Journal of Thoracic Disease, Vol.7, No.12, pp. 2203-2213, 2015. doi: 10.3978/j.issn.2072-1439.2015.12.17
DOI
|
5 |
http://project.swu.ac.kr/copdcap
|
6 |
Rinaudo, Mariano, MD, et al., "Impact of COPD in the Outcome of ICU-Acquired Pneumonia With and Without Previous Intubation", Chest, Vol.147, No.6, pp.1530-1538, 2015. https://doi.org/10.1378/chest.14-2005
DOI
|
7 |
Walters, Julia Ae, et al., "Injectable Vaccines for Preventing Pneumococcal Infection in Patients with Chronic Obstructive Pulmonary Disease", Cochrane Database of Systematic Reviews, No.11, p. CD001390, 2010. https://doi.org/10.1002/14651858.CD001390.pub3
DOI
|
8 |
https://cris.nih.go.kr/cris/use_guide/cris_introduce.jsp
|
9 |
https://www.mdsol.com/en/what-we-do
|
10 |
Biopharmaceutical Evaluation Division "General considerations of clinical trials," Ministry of Food and Drug Safety, 2004. https://www.mfds.go.kr/brd/m_218/view.do?seq=701
|